Who
Ron M. Philip
Director
Company insider
Files Form 4 as: Director, City Therapeutics; Director, Avalo Therapeutics; Director, Harmony Biosciences Holdings.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 2 Apr 2025
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | CTY City Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,649 at $0.00 | filing |
| 30 Sep 2026filed 2 Oct 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $14K1,109 at $12.29 | filing |
| 30 Jun 2026filed 2 Jul 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1,03869 at $15.04 | filing |
| 30 Jun 2026filed 2 Jul 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1,03869 at $15.04 | filing |
| 23 Jun 2026filed 25 Jun 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,200 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,200 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,872 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,872 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,522 at $0.00 | filing |
| 2 Apr 2025filed 4 Apr 2025 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,077 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.